The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy

Shamaila Munir Ahmad, Evelina Martinenaite, Morten Holmström, Mia Aaboe Jørgensen, Özcan Met, Claudia Nastasi, Uffe Klausen, Marco Donia, Lars Møller Pedersen, Lars Munksgaard, Niels Ødum, Anders Woetmann, Inge Marie Svane, Mads Hald Andersen

31 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences